Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      MA01.03 - Exploiting DNA Methylation for Classification of SCLC Subtypes from Liquid Biopsies Using a Robust Machine Learning Approach

      10:47 - 10:52  |  Presenter: Simon Heeke

      • Abstract

      Loading...

  • +

    EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
    • +

      EP07.01-019 - Multiinstitutional Patterns of Use and Compliance with Tumor Treating Fields for Patients with Unresectable Malignant Pleural Mesothelioma

      Presenter: Rupesh Kotecha

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-075 - Combination of Baseline Disease and Smoking Pack-Years Can Guide The 1st-line Treatment Decision in Advanced NSCLC with High PD-L1 Expression

      Presenter: Ren Yuan

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-038 - Study of First-Line Aumolertinib Plus Bevacizumab and Pemetrexed Treated NSCLC with EGFR Mutation and Brain Metastasis

      Presenter: Shuai Fu

      • Abstract

      Loading...

    • +

      EP08.02-139 - A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs

      Presenter: Shun Lu

      • Abstract

      Loading...

    • +

      EP08.02-163 - Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer

      Presenter: Xiuning Le

      • Abstract

      Loading...

  • +

    EP14.03 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RT

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
    • +

      EP14.03-001 - DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive Stage Small Cell Lung Cancer

      Presenter: Aditya Juloori

      • Abstract

      Loading...

  • +

    OA14 - New Techniques to Improve Outcome in Early Stage NSCLC Patients Treated with Surgery or Radiotherapy

    • 12:00 - 13:00
    • 8/09/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Early Stage Non-small Cell Lung Cancer
    • +

      OA14.06 - T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing

      12:22 - 12:32  |  Presenter: Filiz Oezkan

      • Abstract

      Loading...